Please search this website for relevant prescribing guidelines and shared care protocols.
COVID-19 Medicines Optimisation Guidelines
Please see the Staff Zone on the Oxfordshire Clinical Commissioning Group website and Clarity Team Net for all Primary Care COVID-19 updates. If you are unable to access this area (N3 connection required for staff zone and account for clarity), the local medicines related documents are listed below:
- FAQ Document
- Drug Monitoring and Medicines Management During COVID-19
- End of Life Care Symptom Management During COVID-19
- Anticipatory drugs to be used during COVID pandemic for GPs and DNs - process to provide in care homes and patients own home settings
- Lithium information for healthcare professionals
- Clozapine information for healthcare professionals and Clozapine Primary Care Pathway
- OCCG Sip Feed Prescribing in Primary Care during COVID-19
- Hydration Patient Information Leaflet
- Nutrition and Hydration Considerations for Care Homes during COVID-19 Poster
- Vitamin D and Recommendations during COVID-19
- Adrenal Insufficiency COVID-19 Guidelines
- OCCG Nutrition and Hydration Pack for Care Homes to use during the Covid 19 Pandemic
- Guidance on Structured Medication Reviews
Useful national documents:
- Summary of COVID-19 related medication advice from the different medical speciality professional bodies
- COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community
Oxfordshire Prescribing Formulary
Oxfordshire now has a new online Medicines Formulary. This replaces the ‘Oxfordshire Traffic Light Classification for Prescribing Responsibility’ document.
Prescribing Dashboard and Prescribing Incentive Scheme
If you are a GP looking for the primary care prescribing dashboard, please see the Oxfordshire CCG website's prescribing page for the most recent version.
Resources to support GPs achieve their prescribing incentives are available here.
Contact and further information
For any medicines or prescribing related queries and communications, including suggestions for new drugs, shared care protocols or prescribing guidelines for APCO to consider, please email firstname.lastname@example.org.